摘要
Studies on siRNA delivery have seen intense growth in the past decades since siRNA has emerged as a new class of gene therapeutics for the treatment of various diseases. siRNA bioconjugate, as one of the major delivery strategies, offers the potential to enhance and broaden pharmacological properties of siRNA, while minimizing the heterogeneity and stability-correlated toxicology. This review summarizes the recent developments of siRNA bioconjugate, including the conjugation with antibody, peptide, aptamer, small chemical, lipidoid, cell-penetrating peptide polymer, and nanoparticle. These siRNA bioconjugate, either administrated alone or formulated with other agents, could significantly improve pharmacokinetic behavior, enhance the biological half-life, and increase the targetability while maintaining sufficient gene silencing activity, with a concomitant improvement of the therapeutic outcomes and diminishment of adverse effects. This review emphasizes the delivery application of these siRNA bioconjugates, especially the conjugation strategy that control the integrity, stability and release of siRNA bioconjugates. The limitations conferred by these conjugation strategies have also been covered.
| 源语言 | 英语 |
|---|---|
| 期刊论文编号 | 2211 |
| 页数 | 25 |
| 期刊 | MOLECULES |
| 卷 | 24 |
| 期 | 12 |
| DOI | |
| 出版状态 | 已出版 - 2 6月 2019 |
基金资助
This work is supported by the start-up package of Wuhan University.
关键词
- siRNA bioconjugate
- siRNA scaffold
- asymmetric siRNA
- lipid siRNA conjugate
- spherical siRNA
收录
- SCIE
- Scopus
学术指纹
探究 'Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver